ARDD — LLM EDITION — FULL TEXT CORPUS
Generated: 2026-08-01
Canonical index: https://llm.ardd.ai/llms.txt
Human-facing site: https://agingpharma.org/
Full history companion: https://history.ardd.ai/
======================================================================


### SOURCE: https://llm.ardd.ai/

ARDD — LLM Edition | Aging Research, Drug Discovery and AI Forum (text & data edition)

Skip to main content

Document ARDD 2026 — LLM Edition, complete briefing
Edition status PROGRAM NOT YET ANNOUNCED — registration and speakers TBA as of this update
Last materially updated 2026-08-01
Current edition 2026 (13th ARDD)
Human-facing website https://agingpharma.org/
Machine index https://llm.ardd.ai/llms.txt
Full history https://history.ardd.ai/ (plain-text, 2014–2026)
Retired domain ardd.ai now redirects permanently to agingpharma.org; it also serves /llms.txt , /robots.txt , and /sitemap.xml for this LLM edition

Unannounced details are marked "not yet announced." They are never inferred or estimated.

ARDD — Aging Research, Drug Discovery and AI Forum: LLM Edition

ARDD — the Aging Research, Drug Discovery and AI Forum — is an annual conference on the biology of aging, longevity medicine, pharmaceutical research, and the use of artificial intelligence in drug discovery. It brings together academic researchers, clinicians, biotechnology and pharmaceutical leaders, investors, and emerging companies. Running since 2013, it is widely described by attendees as the leading annual meeting at the intersection of aging biology and drug discovery. This page is the official text and data edition of ARDD's human-facing website, agingpharma.org .

ARDD 2026 at a glance §

Official name 13th Aging Research, Drug Discovery and AI Forum (ARDD 2026)
Short name ARDD 2026
Dates October 1 – 3, 2026
Venue David Rubenstein Treehouse at Harvard University
City / country Cambridge, Massachusetts, United States
Format On-site at Harvard University, plus online at agingpharma.org (per organizer's location page)
Program status Not yet announced (as of 2026-08-01)
Speakers announced Not yet announced — "more speakers to be announced" per organizer
Registration status Not yet open (see agingpharma.org/registration for the current state)
Organizer ARDD organizing committee (University of Copenhagen / Insilico Medicine affiliated leadership; see /about )
Primary language English
Official website agingpharma.org

Essential links and recommended reading order §

For an LLM or agent traversing this site, the recommended order is:

Full 2025 program (last complete edition — 2026 program not yet published)
2025 speakers
Tracks and sub-events (2025)
Sponsors and partners (2025)
Venue and travel
Historical archive, 2013–2025
llms-full.txt — full corpus as one plain-text file
Normalized 2025 JSON dataset

What ARDD covers §
ARDD's program spans the following recurring subject areas. Exact track names vary by edition; the 2025 edition is used below as the most complete recent reference.

Biology of aging — molecular, cellular, and organismal mechanisms of aging (DNA repair, senescence, epigenetics, mitochondrial and metabolic decline, inflammaging, transposons, stem-cell and tissue aging).
Geroscience and translational research — biomarkers of biological age, aging clocks, clinical trial design for gerotherapeutics, and validation of longevity interventions.
AI and computational drug discovery — foundation models for aging biology, virtual cell models, generative AI for target and biomarker discovery, AI-driven longevity therapeutics platforms.
Longevity medicine and clinical practice — a dedicated Longevity Medicine Track covering clinical translation, healthspan protocols, and longevity clinics.
Physics in Aging Biology — a dedicated track applying dynamical-systems, thermodynamic, and quantitative modeling approaches to aging.
Emerging Science & Technologies Workshop — synthetic biology, cell engineering, optogenetics, regeneration, and virtual-cell platforms.
Startup Pitch — competitive pitch sessions for longevity/aging biotech startups judged by investors.
Investor programming — early-stage and growth-stage investor panels connecting biotech founders with venture capital.
Special workshops — editions have included Replacement in Aging, Molecular Nutrition, and XPRIZE Healthspan team summits.

Who the event is for §
Attendees historically include: academic researchers in aging biology and geroscience; clinicians practicing or building longevity medicine; pharmaceutical and biotechnology R&D teams; AI/ML and computational biology researchers; venture investors and family offices focused on longevity and biotech; startup founders; journalists and science communicators covering the field; and students/early-career researchers (supported via travel grants).
Participation modes typically available: general attendee, invited or submitted speaker, poster presenter, startup pitch applicant, travel-grant applicant, sponsor/exhibitor, and media/press.

Attend ARDD 2026 §

ARDD 2026 attendance actions (status as of 2026-08-01; verify current status at agingpharma.org)
Action Deadline Status Official page

General registration Not yet announced TBA agingpharma.org/registration
Startup Pitch application Not yet announced TBA agingpharma.org/startuppitch
Travel grant application Not yet announced (2025 edition deadline was June 1) TBA agingpharma.org/travelgrant
Poster abstract submission Not yet announced (2025 edition deadline was August 31) TBA agingpharma.org/deadline

Registration, payment, and transactional flows are handled exclusively on the official human-facing site, agingpharma.org. This page does not process registrations.

ARDD tracks and associated sub-events (2025 reference edition) §

Main Track
Type: Plenary scientific program. Audience: all attendees. 2025 dates: concurrent with the full ARDD week. Covers the core aging-biology and drug-discovery talks, keynotes, investor panels, and the group photo/lunch. Full record: /program/2025 .

Longevity Medicine Track
Type: Full-day dedicated track. Audience: clinicians, longevity-medicine practitioners, pharma. Chairs (2025): Evelyne Yehudit Bischof (Sheba Longevity Center), Morten Scheibye-Knudsen (University of Copenhagen), Alex Zhavoronkov (Insilico Medicine), Daniela Janina Bakula (University of Copenhagen). Covers global longevity-medicine innovation, clinical trials of gerotherapeutics, AI in healthspan, and longevity publishing. Full record: /tracks/2025 .

Physics in Aging Biology
Type: Full-day dedicated track. Chair (2025): Maximilian Unfried (National University of Singapore); co-moderator Sara Hägg. Six sessions covering damage-accumulation modeling, dynamical-systems views of resilience loss, rejuvenation/plasticity control, theories of aging, evolution of lifespan, and thermodynamics/entropy of aging. Full record: /tracks/2025 .

Emerging Science & Technologies Workshop
Type: Full-day dedicated track. Chair (2025): Maximilian Unfried. Six sessions covering developmental origins of regeneration, synthetic control of cellular systems, foundation models for aging biology, virtual cells, and structural engineering of rejuvenation. Full record: /tracks/2025 .

Startup Pitch
Type: Competitive pitch sessions with investor jury. 2025 moderator: Clive Cookson (Financial Times). 2025 judges included: Jacob Falck Hansen (Lundbeckfonden BioCapital), Marc P. Bernegger (Maximon), Anne Marije van Harten (Apollo Health Ventures). Ten companies presented across two blocks. Full record: /tracks/2025 .

Prior editions have also included: Replacement in Aging Workshop (2025), Molecular Nutrition Workshop (2025), and the XPRIZE Healthspan Team Summit (2024). See /history for details.

Complete ARDD 2025 program (last fully published edition) §
Program status: final/completed. Edition: 12th ARDD, 2025. Full record with day-by-day schedule tables: /program/2025 . Full speaker roster: /speakers/2025 . A representative excerpt of the Main Track day is below; the complete schedule (all tracks, all sessions) is on the linked pages.

ARDD 2025 — Main Track, excerpt (see /program/2025 for the complete schedule)
Time Session / talk Speaker Affiliation

09:10–09:30 Predictions, Tools, and Updates from the Study of Longitudinal Aging in Mice (SLAM) Rafael de Cabo National Institute on Aging
09:50–10:10 When a calorie is not just a calorie: dietary macronutrients, health and longevity Dudley Lamming University of Wisconsin–Madison
10:30–10:50 Muscling in on mitochondrial aging: skeletal muscle as driver and target of bioenergetic decline Lykke Sylow University of Copenhagen
11:10–11:30 Subliminal hypoxia and accelerated aging Luigi Ferrucci National Institute on Aging
13:00–13:20 Data-driven interventions in human aging Morten Scheibye-Knudsen University of Copenhagen
15:05–15:20 Universal transcriptomic hallmarks of mammalian aging and mortality across species and cell types Alexander Tyshkovskiy Harvard Medical School
16:40–17:00 Targeting selective autophagy: ensuring healthy longevity one protein at a time Ana Maria Cuervo Albert Einstein College of Medicine
20:15–20:55 Investor Panel — Early Stage (moderated) Tom Zuber (mod.); Garri Zmudze; William Harborne; Anne Marije van Harten Zuber Lawler; LongeVC; LongGame; Apollo Health Ventures

ARDD 2025 speakers (selected; full roster at /speakers/2025) §
The 2025 edition included well over 100 confirmed speakers, moderators, and pitch judges. A representative subset spanning the program's breadth is listed below; the complete alphabetized roster with affiliations and roles is at /speakers/2025 .

ARDD 2025 speakers — representative subset
Speaker Affiliation Note

Morten Meldal University of Copenhagen 2022 Nobel Laureate in Chemistry (Click chemistry)
Michael Levitt Stanford School of Medicine Nobel Laureate in Chemistry (2013); Physics in Aging Biology
Vadim Gladyshev Harvard Medical School Quantifying and targeting aging
Steve Horvath — Frontiers in epigenetic clocks
Tony Wyss-Coray Stanford University Circulatory biomarkers of brain aging
Thomas Rando — Epigenetic reprogramming, local and distant rejuvenating effects
Alex Zhavoronkov Insilico Medicine Discovery and development of longevity therapeutics; Longevity Medicine Track co-founder
Ana Maria Cuervo Albert Einstein College of Medicine Selective autophagy and longevity
Jean-Marc Lemaitre INSERM Reprogramming aging as a gateway to disease prevention
Brian Kennedy National University of Singapore Validating and implementing longevity interventions
Nir Barzilai Albert Einstein College of Medicine From pathways to patients: translating geroscience
James Kirkland Robert and Arlene Kogod Center on Aging Clinical trials and future directions of gerotherapeutics
Andrea Maier National University of Singapore Clinical trials in geroscience
Miriam Merad — Targeting inflammaging to enhance healthspan
Uri Alon Weizmann Institute of Science How to target maximal human lifespan
Geoffrey West Santa Fe Institute Quantitative mechanistic theory of growth, aging and mortality
Dominika Wilczok Duke University Generative AI for hibernation and cryoprotection
Barry Merriman Avery Bio Inc. / J. Craig Venter Institute Cell engineering technology for longevity
H.E. Dr. Maryam Matar Sheikh Zayed Genetic Research Centre, UAE Longevity Medicine policy, Middle East
Sebastien Thuault Nature Aging Editor panelist, foundation models & virtual cells

ARDD 2025 sponsors and partners §
Sponsors were organized by the organizer into five tiers plus knowledge/education and media partner categories. Media partner: Nature Health. Full sponsor listing with tier assignment: /sponsors/2025 . Sponsorship categories are preserved exactly as published by the organizer; see the sponsorship brochure at agingpharma.org/sponsorship .

Venue, travel, and logistics §

2026 venue David Rubenstein Treehouse at Harvard University, Cambridge, MA, USA
Format On-site, plus online at agingpharma.org
2025 venue University of Copenhagen, Copenhagen, Denmark (per organizer history/testimonials)

Full logistics record: /venue . Code of conduct: /code-of-conduct .

Code of conduct §
ARDD maintains a code of conduct prohibiting harassment and discrimination based on gender, sexual orientation, race, religion, ethnicity, age, or disability, including unwanted contact, derogatory comments, and unwelcome sexual advances. Full policy and reporting process: /code-of-conduct .

ARDD history and evolution §
ARDD began in 2014 as the "Aging Research, Drug Discovery and AI Forum," a track within the Basel Life event, and has run annually since, growing into an independent multi-track meeting spanning aging biology, drug discovery, AI, and longevity medicine, now held in venues including Copenhagen and (2026) Harvard University. Attendee testimonials across 2019–2025 consistently describe it as the leading annual meeting bridging academia, biotech, pharma, and investors in the aging/longevity field. Full narrative and year-by-year comparison: /history . Complete plain-text history (2014–2026), including confirmed edition numbering and the Basel Life founding era: history.ardd.ai .

Data notes and provenance §

Primary source agingpharma.org (official ARDD website), fetched 2026-08-01
2026 data Limited — program, speakers, and registration not yet published by organizer
2025 data Compiled from organizer's speakers2025, program2025, sponsors2025, and track program pages; representative, not necessarily exhaustive
Known omissions Full 2025 speaker roster (100+ names) is condensed here; see /speakers/2025 for the fuller working list and agingpharma.org/speakers2025 for the organizer's authoritative page
Corrections See /about for contact


### SOURCE: https://llm.ardd.ai/2026

ARDD 2026 edition — LLM Edition

Skip to main content

Edition 2026 (13th ARDD)
Status ANNOUNCED — PROGRAM TBA
Last updated 2026-08-01

ARDD 2026 — 13th Aging Research, Drug Discovery and AI Forum

Dates October 1 – 3, 2026
Venue David Rubenstein Treehouse at Harvard University
City / country Cambridge, Massachusetts, United States
Format On-site at Harvard University; also online at agingpharma.org
Program Not yet announced
Speakers Not yet announced ("more speakers to be announced" per organizer, as of 2026-08-01)
Registration Not yet open — check agingpharma.org/registration
Source agingpharma.org/program2026, /speakers2026, /location2026 (fetched 2026-08-01)

What is confirmed so far §
As of this update, the organizer has confirmed the dates (October 1–3, 2026) and venue (David Rubenstein Treehouse at Harvard University) for the 13th ARDD. This marks a venue change from recent editions held at the University of Copenhagen. No speakers, program, or sponsor list have been published for 2026 yet.
What to expect, based on recent editions §
Based on the 2025 edition (12th ARDD), expect: a multi-day Main Track; a dedicated Longevity Medicine Track; a Physics in Aging Biology track; an Emerging Science & Technologies Workshop; a Startup Pitch competition; and investor panels (early-stage and growth-stage). See /tracks/2025 and /program/2025 for the most recent complete reference.
How to get current 2026 details §
This page will be updated as the organizer publishes 2026 details. For the latest information right now, check the official pages: program2026 , speakers2026 , registration , sponsors2026 .


### SOURCE: https://llm.ardd.ai/program/2025

ARDD 2025 program — LLM Edition

Skip to main content

Edition ARDD 2025 (12th ARDD), Main Track
Program status FINAL / COMPLETED
Timezone Europe/Copenhagen (CEST, UTC+2)
Source agingpharma.org/program2025 (fetched 2026-08-01)

ARDD 2025 — Main Track program
For the dedicated tracks (Longevity Medicine, Physics in Aging Biology, Emerging Science & Technologies Workshop, Startup Pitch), see /tracks/2025 , which run in parallel to and alongside the Main Track described here.

Main Track — Day schedule §

ARDD 2025 Main Track — complete published schedule
Time Session / talk Speaker Affiliation

08:00–09:00 Registrations, coffee, tea — —
09:00–09:10 Welcome — —
09:10–09:30 Predictions, Tools, and Updates from the Study of Longitudinal Aging in Mice (SLAM) Rafael de Cabo National Institute on Aging
09:50–10:10 When a calorie is not just a calorie: the regulation of health and longevity by dietary macronutrients Dudley Lamming University of Wisconsin–Madison
10:10–10:30 Break — —
10:30–10:50 Muscling in on mitochondrial aging: skeletal muscle as a driver and target of bioenergetic decline Lykke Sylow University of Copenhagen
11:10–11:30 Subliminal hypoxia and accelerated aging Luigi Ferrucci National Institute on Aging
11:30–13:00 Lunch and group photo — —
13:00–14:00 Session chair Peter Fedichev Gero
13:00–13:20 Data-driven interventions in human aging Morten Scheibye-Knudsen University of Copenhagen
13:20–13:40 Spatial mapping of aged and senescent brain cell fates Marissa Schafer Mayo Clinic
13:40–14:00 Transposons in aging and reproductive aging Andrei Seluanov University of Rochester
14:00–14:20 Coffee break — —
14:20–14:35 Spatial and molecular reorganization of cerebellar microglia with aging Andy Poyi Tsai Stanford University
14:35–14:50 Identification of deubiquitinating enzymes (DUBs) regulating seeded tau aggregation: therapeutic strategies for tauopathies Christiane Volbracht Lundbeck
14:50–15:05 Targeting CD38 immunometabolic checkpoint to supercharge T cell immunity in Alzheimer's disease Javier María Peralta Ramos Weizmann Institute of Science
15:05–15:20 Universal transcriptomic hallmarks of mammalian aging and mortality across species and cell types Alexander Tyshkovskiy Harvard Medical School
15:20–16:00 Coffee break and poster session — —
16:00–16:20 The 5 "A"s: ageing, autophagy, Alzheimer's, Artificial intelligence, and an "A molecule" in healthy longevity Evandro Fang University of Oslo
16:20–16:40 Epigenetic reprogramming of cell fates: mechanisms and applications Ethan Liu Westlake University
16:40–17:00 Targeting selective autophagy: ensuring healthy longevity one protein at a time Ana Maria Cuervo Albert Einstein College of Medicine
17:00–17:20 Coffee break — —
18:20–19:00 Dinner — —
19:00–19:20 Lessons from COVID-19: reducing global vulnerability in the age of longevity Michael Levitt Stanford University
20:00–20:15 Break — —
20:15–20:55 Investor Panel — Early Stage: Garri Zmudze (LongeVC); William Harborne (LongGame); Anne Marije van Harten (Apollo Health Ventures) Tom Zuber (moderator) Zuber Lawler
21:00–21:40 Investor Panel — Growth Stage: Murali Venkatesan (Danaher Corporation); Kitsu Egerton (Baillie Gifford); Daisy Cai (B Capital) Tom Zuber (moderator) Zuber Lawler

Additional 2025 talks (from published video/recording index) §
The organizer's video archive lists additional talks presented at ARDD 2025 whose exact time slot was not captured in the schedule excerpt above. These are included here for completeness since they are confirmed program content:

Additional confirmed ARDD 2025 talks (time slot not specified in source)
Talk Speaker Affiliation

Quantitative and dynamic analysis of organismal aging Anne Brunet —
Targeting CD38 against aging Eric Verdin —
Discovery and Development of Longevity Therapeutics: When Should We... Alex Zhavoronkov Insilico Medicine
Mechanisms of Ovarian Aging: A Target for Geroprotection in Women Yousin Suh —
Engineering the Path to Radical Life Extension Maxim Kholin —
Genomic Insights into Reproductive Ageing Anna Murray —
DNA damage and Aging: the impact of nutrition, gene size and... Jan Hoeijmakers —
Building an AI Research Collective for Longevity Discovery Kennedy Schaal —
The Aging Genome: From Mechanisms to Interventions Björn Schumacher University of Cologne
A novel disease-modifying osteoarthritis drug affecting cartilage... Martin Borch Jensen —
Aging of Elastin: From Structural Decay to Therapeutic Potential Andrea Heinz University of Copenhagen
Rapid Skin Senescence Switch: A Druggable Checkpoint for... Tomaz Rozmaric —
Restoration of biological age during prolonged fasting-refeeding... Kazuto Kawamura —
Telomeres, Transcriptomes and Troubles: Bats as new models of extended... Emma Teeling —
Towards Integrated Multi-Level Physics and ML for Aging and Drug... Michael Antonov —
Endogenous amyloid beta promotes spontaneous brain aging... Dario Riccardo Valenzano —
The anti-inflammatory role of exercise Bente Klarlund —
Global Innovations Landscape in XPRIZE Healthspan Jamie Justice —
Lying Still, Falling Fast: How Hospital Beds Accelerate Aging Charlotte Suetta —
A new, translational paradigm for pre-clinical drug testing Steve Austad University of Alabama at Birmingham
Organ Protection with GLP-1 Receptor Agonists Lotte Bjerre Knudsen —
Accelerating translational geroscience: new training programs, centers... John Newman —
Metabolic drivers of aging Peter Mullen —
Optimal diets for healthy aging Marta Guasch-Ferré —
Redrawing the Health Care Map: From Pushing at Boundaries to Redefining... Andrew Adams —
Generative AI Applications in the Analysis of Photographic... Anastasia Georgievskaya —
Drug discovery for developing regenerative pharmacological... Collin Ewald —
Use of potential gerotherapeutic drugs and mortality in geriatric... Weilan Wang —
GDF3 promotes adipose tissue macrophage-mediated inflammation via... In Hwa Jang —
DREAM complex activity as a determinant of somatic mutation rate and lifespan Zane Koch —
Heritability of human lifespan is about ~50% when confounding factors... Ben Shenhar —
Biomarkers of Senescence: From Research to Clinical Practice Nathan Le Brasseur —
MicroRNAs: new epigenetic targets for skin longevity and beauty... Elias Bou Samra —
Validating and Implementing Longevity interventions Brian Kennedy National University of Singapore
Purinergic signaling as a vulnerable node of detrimental senescence Marco Demaria ERIBA
Tracking skin health: non-invasive epigenetic biomarker proxies to... Cristiana Banila —
Development of novel geroprotectors to extend healthspan Laura Niedernhofer UMN
hTSC-Derived Exosomes: Targeting Senescence and Age... Yuta Lee and Kotb Abdelmohsen National Institute on Aging, NIH
Quantifying and Targeting Aging Vadim Gladyshev Harvard Medical School
Brain Aging and Blood Factors Lida Katsimpardi —
Circulatory biomarkers of brain aging Tony Wyss-Coray Stanford University
4 years into longevity investing: takeaways deploying an early stage... Sergey Jakimov —
From Disease to Discovery: Leveraging IPF Aging Biology for Novel... Fedor Galkin Insilico Medicine
Frontier Jurisdictions & Changing the Regulatory Paradigm for Longevity Niklas Anzinger —
Closing the Gaps in Aging Biology via a Coordinated Approach Todd White The Thalion Initiative
Clinical development of RJx-01 as a novel combination drug for the... Jeroen Aerssens —
2025: An update in DNAm algorithms and Aging interventional data Ryan Smith —
Frontiers in Epigenetic Clocks: Unlocking Longevity Steve Horvath —
From Lab to Ledger: How DeSci is Accelerating Drug Discovery for... Paul Kohlhaas —
Molecular regulation of NAD+ homeostasis in human aging Riekelt Houtkooper —
Intersection of tumorigenesis and aging-associated decline in lung... Tuomas Tammela —
Targeting inflammaging to enhance health span Miriam Merad —
LifeBiosciences (presentation) Sharon Rosenzweig-Lipson Life Biosciences
Epigenetic reprogramming: local and distant rejuvenating effects Thomas Rando —
Reprogramming Aging as a Gateway to Disease Prevention and... Jean-Marc Lemaitre INSERM
Measure and Intervene Aging with AI Jackie Han —
Tweaking behavior and processing of Alzheimer's Aβ-Peptides with... Morten Meldal University of Copenhagen
Imaging of chromatin and epigenetics reveals cell identity and... Alexey Terskikh —

Source: agingpharma.org video/recording index for ARDD 2025 (fetched 2026-08-01). Time slots for these talks were not specified in the source and are marked accordingly.


### SOURCE: https://llm.ardd.ai/speakers/2025

ARDD 2025 speakers — LLM Edition

Skip to main content

Edition ARDD 2025 (12th ARDD)
Source agingpharma.org/speakers2025 (fetched 2026-08-01)
Completeness Partial — organizer page lists 100+ speakers; this record contains the fully-fetched subset plus all speakers appearing in program/track pages. See note below.

ARDD 2025 speakers
ARDD 2025 (the 12th annual ARDD) featured well over 100 confirmed speakers, moderators, session chairs, and Startup Pitch judges spanning aging biology, drug discovery, AI, longevity medicine, and investment. The table below lists every speaker captured from the organizer's speakers page and all track/program pages as of this update, alphabetized by family name where determinable.
Note on completeness: the organizer's speakers2025 page is long-form prose without stable per-person anchors; this table reflects a full pass over the available content plus every name appearing in the Main Track, Longevity Medicine Track, Physics in Aging Biology, Emerging Tech Workshop, and Startup Pitch program pages. If a name is missing, check agingpharma.org/speakers2025 directly and see /about to report a correction.

ARDD 2025 speakers, moderators, and judges
Name Affiliation Role / session context

Kotb Abdelmohsen National Institute on Aging, NIH Speaker — RNA-binding proteins & senescence
Omar Abudayyeh Broad Institute of MIT and Harvard Speaker — virtual models for regenerative therapeutics; panelist
Andrew Adams — Speaker — redrawing the healthcare map
Jeroen Aerssens — Speaker — clinical development of RJx-01
Alejandro Aguilera-Castrejon HHMI Janelia Research Campus Speaker — ex utero mouse embryogenesis
Uri Alon Weizmann Institute of Science Speaker — maximal human lifespan (Physics in Aging Biology)
Niklas Anzinger — Speaker — frontier jurisdictions & regulatory paradigm for longevity
Michael Antonov — Speaker — integrated multi-level physics & ML for aging
Steve Austad University of Alabama at Birmingham Speaker — translational paradigm for pre-clinical drug testing
Neda Bagheri University of Washington, Seattle Speaker — spatiotemporal cell population dynamics (Physics in Aging Biology)
Daniela Janina Bakula University of Copenhagen Longevity Medicine Track — welcome/chair
Cristiana Banila — Speaker — epigenetic biomarker proxies for skin health
Nir Barzilai Albert Einstein College of Medicine Speaker — from pathways to patients: geroscience to gerotherapeutics
Marc P. Bernegger Maximon Startup Pitch judge
Andreas Beyer University of Cologne Speaker — disentangling cellular damage from biological age (Physics in Aging Biology)
Evelyne Yehudit Bischof Sheba Longevity Center Longevity Medicine Track — chair/moderator
Elena Bonfiglioli Microsoft (Pharma and Life Sciences) Speaker — AI in precision medicine; panelist
Elias Bou Samra — Speaker — microRNAs, epigenetic targets for skin longevity
Anne Brunet — Speaker — quantitative/dynamic analysis of organismal aging
Sam Burrows NHS Frimley ICB Panelist — AI in healthspan
Patrick Burgermeister Kizoo Technology Capital Testimonial contributor (historical)
Elise Cachat University of Edinburgh Speaker — synthetic receptor sensor/actuator systems
Daisy Cai B Capital Investor panelist — growth stage
Andrea Cipriano Stanford Stem Cell Institute Speaker — Biomarkers of Aging Consortium updates
Clive Cookson Financial Times Startup Pitch — moderator
Ana Maria Cuervo Albert Einstein College of Medicine Speaker — targeting selective autophagy
Marija Cvijovic University of Gothenburg Speaker — Ctrl+Z ageing modeling (Physics in Aging Biology)
Rafael de Cabo National Institute on Aging Speaker — Study of Longitudinal Aging in Mice (SLAM)
Marco Demaria ERIBA / Aging journal Speaker — purinergic signaling and senescence; publishing panelist
Dominik Duscher MuseCell Innovations Speaker — Muse Cells
Collin Ewald — Speaker — drug discovery for regenerative pharmacology
Evandro Fang University of Oslo Speaker — the "5 A's": ageing, autophagy, Alzheimer's, AI
Peter Fedichev Gero Main Track session chair; speaker — entropic damage & aging (Physics in Aging Biology)
Luigi Ferrucci National Institute on Aging Speaker — subliminal hypoxia and accelerated aging
Benjamin Friedrich Cluster of Excellence "Physics of Life" Speaker — axolotl limb regeneration model
Fedor Galkin Insilico Medicine Speaker — IPF aging biology for novel discovery
Anastasia Georgievskaya — Speaker — generative AI in photographic analysis
Vadim Gladyshev Harvard Medical School Speaker — quantifying and targeting aging
Marta Guasch-Ferré — Speaker — optimal diets for healthy aging
Jean-Marc Lemaitre INSERM Speaker — reprogramming aging; publishing panelist
Nan Hao UC San Diego Speaker — computationally-guided reprogramming of single-cell aging
Sara Hägg Karolinska Institute Physics in Aging Biology — co-moderator; speaker
William Harborne LongGame Investor panelist — early stage
Jacob Falck Hansen Lundbeckfonden BioCapital Startup Pitch judge
Anne Marije van Harten Apollo Health Ventures Investor panelist / Startup Pitch judge
Lars Hartenstein McKinsey Health Institute Speaker
Wei-Wu He Human Longevity Inc. Panelist — AI in healthspan
Jan Hoeijmakers — Speaker — DNA damage and aging, nutrition and gene size
Steve Horvath — Speaker — frontiers in epigenetic clocks
Riekelt Houtkooper — Speaker — NAD+ homeostasis in human aging
In Hwa Jang — Speaker — GDF3 and adipose tissue macrophage inflammation
Sergey Jakimov — Speaker — longevity investing takeaways
Jackie Han — Speaker — measure and intervene aging with AI
Jamie Justice — Speaker — XPRIZE Healthspan innovations landscape
Lida Katsimpardi — Speaker — brain aging and blood factors
Kazuto Kawamura — Speaker — biological age restoration via fasting-refeeding
Brian Kennedy National University of Singapore Speaker — validating and implementing longevity interventions
Maxim Kholin — Speaker — engineering the path to radical life extension
Bente Klarlund — Speaker — anti-inflammatory role of exercise
Zane Koch — Speaker — DREAM complex, somatic mutation rate, lifespan
Paul Kohlhaas — Speaker — DeSci accelerating drug discovery
Axel Kowald Institute for Biostatistics & Informatics in Medicine and Ageing Research Speaker — rate of aging (Physics in Aging Biology)
Anton Kulaga Institute for Biostatistics and Informatics in Medicine and Ageing Research Speaker — Holy-Bio-MCP
Dudley Lamming University of Wisconsin–Madison Speaker — dietary macronutrients, health and longevity
Nathan Le Brasseur — Speaker — biomarkers of senescence
Yuta Lee — Co-speaker (with Kotb Abdelmohsen) — hTSC-derived exosomes
Michael Levitt Stanford School of Medicine Nobel Laureate; speaker — lessons from COVID-19
Chuen Yan Leung Value Partners Group Panel moderator — AI in healthspan
Peter Lidsky City University of Hong Kong Speaker — evolution of adaptive death (Physics in Aging Biology)
Ethan Liu Westlake University Speaker — epigenetic reprogramming of cell fates
Sophia Liu Ragon Institute of MGB, MIT, and Harvard Speaker — architectures of immunological aging
Sebastian Lobentanzer Helmholtz Center Speaker/panelist — biomedical context for agents
Sierra Lore Buck Institute for Research on Aging Speaker — replacement as an aging intervention
Lucia Marucci University of Bristol Speaker/panelist — designing genomes with whole-cell models
Maryam Matar (H.E. Dr.) Sheikh Zayed Genetic Research Centre, UAE Speaker — longevity medicine policy
Morten Meldal University of Copenhagen 2022 Nobel Laureate in Chemistry; speaker
Miriam Merad — Speaker — targeting inflammaging
Barry Merriman Avery Bio Inc. / J. Craig Venter Institute Speaker — cell engineering for longevity
David Helmut Meyer CECAD, University of Cologne Speaker — aging clocks and entropy (Physics in Aging Biology)
Lisa Melton Nature Biotechnology Speaker/panelist — longevity publishing
Rusty Montgomery BioAge Speaker
Anna Murray — Speaker — genomic insights into reproductive ageing
John Newman — Speaker — accelerating translational geroscience training
Hilde Loge Nilsen Oslo University Hospital / AgeLab.no Speaker — DNA/RNA repair and neurodegeneration
Kitsu Egerton Baillie Gifford Investor panelist — growth stage
Charlotte Owen-Woods Cell / Cell Press Speaker/panelist — longevity publishing
Garegin A. Papoian Deep Origin Speaker — physics- and AI-based simulation of proteins/pathways
Javier María Peralta Ramos Weizmann Institute of Science Speaker — CD38 immunometabolic checkpoint
Shahaf Peleg FBN Dummerstorf Speaker — synthetic energy and lifespan interventions
Léo Pio-Lopez Allen Discovery Center at Tufts University Speaker — aging, goal-directedness, bioelectricity
Glen Pridham Weizmann Institute of Science Speaker — menopause transition, lab test data
Peter Mullen — Speaker — metabolic drivers of aging
Naveh Raz Weizmann Institute of Science Speaker — damage accumulation model across species
Thomas Rando — Speaker — epigenetic reprogramming rejuvenation
Yusuf Roohani Stanford University Speaker/panelist — building a virtual cell
Tomaz Rozmaric — Speaker — skin senescence switch
Steffen Rulands Ludwig-Maximilians-Universität München Speaker — timescale of epigenetic ageing
Edward Rudnic — Speaker — longevity peptides, microbiome, gut-brain axis
Wanviput Sanphasitvong Bumrungrad International Hospital / VitalLife Speaker
Marissa Schafer Mayo Clinic Speaker — spatial mapping of aged/senescent brain cell fates
Morten Scheibye-Knudsen University of Copenhagen Speaker; Longevity Medicine Track co-chair
Tomás Schmauck-Medina University of Oslo Speaker — theoretical foundation for aging biology
Björn Schumacher University of Cologne Speaker — the aging genome (video program)
Kennedy Schaal — Speaker — AI research collective for longevity discovery
Andrei Seluanov University of Rochester Speaker — transposons in aging and reproductive aging
Elena G. Sergeeva Tufts University / Wyss Institute at Harvard Speaker — aging as a default state of life
Gareth Shepherd NHS / AFAR Panelist — AI in healthspan
Ben Shenhar — Speaker — heritability of human lifespan
Vanessa Sinatti Aptah Bio Speaker — U1 snRNP in age-related disease
Mirre J P Simons University of Sheffield Speaker — asymmetrical regulation of physiology
Ryan Smith — Speaker — DNAm algorithms and aging interventional data
Tzipora Strauss Sheba Medical Center Speaker — SHARP Study
Charlotte Suetta — Speaker — hospital beds and accelerated aging
Yousin Suh — Speaker — mechanisms of ovarian aging
Lykke Sylow University of Copenhagen Speaker — mitochondrial aging in skeletal muscle
Tuomas Tammela — Speaker — tumorigenesis and aging-associated lung decline
Emma Teeling — Speaker — bats as models of extended longevity
Alexey Terskikh — Speaker — chromatin/epigenetics imaging and cell identity
Sebastien Thuault Nature Aging Speaker/panel moderator — foundation models & virtual cells; publishing panelist
Andy Poyi Tsai Stanford University Speaker — cerebellar microglia reorganization with aging
Ala Trusina University of Copenhagen Speaker — inflammation transitions in pancreatic islets
Alexander Tyshkovskiy Harvard Medical School Speaker — universal transcriptomic hallmarks of aging
Maximilian Unfried National University of Singapore Session chair — Physics in Aging Biology & Emerging Tech Workshop; speaker — maximum lifespan control
Dario Riccardo Valenzano — Speaker — amyloid beta and spontaneous brain aging
Denis Villemonais IRMA, University of Strasbourg Speaker — telomere length dynamics modeling
Christiane Volbracht Lundbeck Speaker — deubiquitinating enzymes in tauopathy
Weilan Wang — Speaker — gerotherapeutic drugs and mortality in geriatric populations
Jeffrey West H. Lee Moffitt Cancer Center & Research Institute Speaker — antifragility in medicine (Physics in Aging Biology)
Geoffrey West Santa Fe Institute Speaker — quantitative theory of growth, aging, mortality
Todd White The Thalion Initiative Speaker — coordinated approach to closing gaps in aging biology
Max Wilson UC Santa Barbara Speaker — optogenetic engineering of cellular signaling
Dominika Wilczok Duke University Speaker — generative AI for hibernation and cryoprotection
Jun Wu UT Southwestern Medical Center Speaker — human blastoids and implantation
Tony Wyss-Coray Stanford University Speaker — circulatory biomarkers of brain aging
Maximina Hee Yun Chinese Institutes for Medical Research Speaker — axolotl regeneration and aging
Bohan Zhang Harvard Medical School Speaker — rejuvenation via heterochronic tissue interaction
Wenting Zhao Nanyang Technological University Speaker — nuclear structure in aging cells
Alex Zhavoronkov Insilico Medicine Longevity Medicine Track co-chair; speaker — longevity therapeutics discovery & development
Garri Zmudze LongeVC Investor panelist — early stage
Tom Zuber Zuber Lawler Investor panel moderator (early & growth stage)
Murali Venkatesan Danaher Corporation Investor panelist — growth stage

Full session-by-session mapping of each speaker to their exact talk title and time is on /program/2025 and /tracks/2025 .


### SOURCE: https://llm.ardd.ai/tracks/2025

ARDD 2025 tracks and sub-events — LLM Edition

Skip to main content

Edition ARDD 2025 (12th ARDD)
Source agingpharma.org track program pages (fetched 2026-08-01)

ARDD 2025 tracks and sub-events

Longevity Medicine Track §
Chairs: Evelyne Yehudit Bischof (Sheba Longevity Center), Morten Scheibye-Knudsen (University of Copenhagen), Alex Zhavoronkov (Insilico Medicine), Daniela Janina Bakula (University of Copenhagen). Opening remarks: David Dreyer Lassen, Rector of the University of Copenhagen.

Longevity Medicine Track — full schedule
Time Session / talk Speaker(s) Affiliation

08:00–09:00 Warming up and networking — —
09:00–09:15 Opening remarks David Dreyer Lassen Rector, University of Copenhagen
09:15–09:30 Welcome to Longevity Medicine Track Bischof, Scheibye-Knudsen, Zhavoronkov, Bakula Sheba Longevity Center; U. Copenhagen; Insilico Medicine
09:30–09:50 TopTown SuperDNA: China and beyond Alex Zhavoronkov Insilico Medicine
09:50–10:10 Microsoft Healthcare in AI precision medicine Elena Bonfiglioli Microsoft, Pharma and Life Sciences
10:25–10:50 Coffee break — —
10:50–11:10 Clinical trials and future directions of gerotherapeutics James Kirkland Robert and Arlene Kogod Center on Aging
11:10–11:30 From pathways to patients: translating geroscience into gerotherapeutics Nir Barzilai Albert Einstein College of Medicine
11:30–11:50 Healthspan protocol in clinical practice Evelyne Yehudit Bischof Sheba Longevity Center
11:50–13:00 Lunch — —
13:00–13:20 Clinical trials in geroscience and gerotherapeutics Andrea Maier National University of Singapore
13:40–14:00 SHARP Study at Sheba Longevity Center Tzipora Strauss Longevity Center at Sheba Medical Center
14:20–14:40 Coffee break — —
14:40–15:25 Panel: AI in healthspan Levitt, Bonfiglioli, Shepherd, Burrows, He (panelists); Leung, Bischof (moderators) Stanford; Microsoft; NHS/AFAR; NHS Frimley ICB; Human Longevity Inc.; Value Partners Group; Sheba
15:35–15:55 Biomarkers of Aging Consortium — updates Andrea Cipriano Stanford Stem Cell Institute
16:55–17:15 Coffee break — —
17:15–18:00 Panel: longevity publishing Johnson, Demaria, Melton, Jin, Thuault, Owen-Woods (panelists); Bischof (moderator) Nature Health; Aging; Nature Biotechnology; Aging and Disease; Nature Aging; Cell
17:15–18:00 Closing of the day Evelyne Yehudit Bischof Sheba Longevity Center
18:00 Dinner — —

Physics in Aging Biology §
Chair: Maximilian Unfried (National University of Singapore). Co-moderator: Sara Hägg (Karolinska Institute, Associate Editor npj Aging).

Physics in Aging Biology — full schedule, six sessions
Time Session / talk Speaker Affiliation

09:00–09:10 Opening Maximilian Unfried; Sara Hägg NUS; Karolinska Institute
Session 1 — Modelling Molecular Mechanisms and Damage
09:10–09:30 Probabilistic modelisation of telomere length dynamics Denis Villemonais IRMA, University of Strasbourg
09:30–09:50 Mechanistic modelling of biochemical pathways for ageing research Amy Morgan University of Salford
09:50–10:10 Crossing scales in aging biology: physics- and AI-based simulations of proteins and pathways Garegin A. Papoian Deep Origin
10:10–10:20 A damage accumulation model reveals mechanisms of aging across species Naveh Raz Weizmann Institute of Science
10:20–10:40 Coffee break — —
Session 2 — Emergence, Dynamics, and Systems Biology
10:40–11:00 From eigenmodes to aging: a dynamical systems perspective on resilience loss Jan Gruber National University of Singapore
11:00–11:20 Can we Ctrl+Z ageing? Modelling the rules, breaking the limits Marija Cvijovic University of Gothenburg
11:20–11:40 Computational models forecast emergent spatiotemporal cell population dynamics Neda Bagheri University of Washington, Seattle
11:40–11:50 Tentative evidence that the rate of aging is controlled by a small number of interacting processes Axel Kowald Institute for Biostatistics & Informatics in Medicine and Ageing Research
12:00–13:00 Lunch break — —
Session 3 — Rejuvenation, Plasticity, and Control
13:00–13:20 Disentangling cellular damage from biological age Andreas Beyer University of Cologne
13:20–13:40 A model for growth control in axolotl limb regeneration Benjamin Friedrich Cluster of Excellence "Physics of Life"
13:40–14:00 The menopause transition characterized using millions of lab tests Glen Pridham Weizmann Institute of Science
14:00–14:10 Aging by the clock and yet without a program David Helmut Meyer CECAD, University of Cologne
14:10–14:20 Aging, goal-directedness and bioelectricity Léo Pio-Lopez Allen Discovery Center at Tufts University
14:20–14:40 Coffee break — —
Session 4 — Theories of Aging
14:40–15:00 Towards a general quantitative mechanistic theory of growth, aging and mortality Geoffrey West Santa Fe Institute
15:00–15:20 How to target maximal human lifespan? Uri Alon Weizmann Institute of Science
15:20–15:30 Aging as a default state of life Elena G. Sergeeva Tufts University / Wyss Institute at Harvard
15:30–15:40 A need for a theoretical foundation on the biology of aging Tomás Schmauck-Medina University of Oslo
15:40–16:00 Coffee break — —
Session 5 — Evolution, Lifespan, and Adaptation
16:00–16:20 Evolution of adaptive death shaped by infectious diseases Peter Lidsky City University of Hong Kong
16:20–16:40 Maximum lifespan control in mammals Maximilian Unfried National University of Singapore
16:40–17:00 Ecological, evolutionary, and interventional antifragility in medicine Jeffrey West H. Lee Moffitt Cancer Center & Research Institute
17:00–17:10 The evolution of asymmetrical regulation of physiology is central to aging Mirre J P Simons University of Sheffield
17:10–17:30 Coffee break — —
Session 6 — Thermodynamics, Time, and Entropy
17:30–17:50 What sets the time scale of epigenetic ageing? Steffen Rulands Ludwig-Maximilians-Universität München
17:50–18:10 Tipping-point transition from transient to persistent inflammation in pancreatic islets Ala Trusina University of Copenhagen
18:10–18:30 Aging from the second law: entropic damage, effective temperature, and extreme-statistics control of lifespan Peter Fedichev Gero

Emerging Science & Technologies Workshop §
Chair: Maximilian Unfried (National University of Singapore).

Emerging Science & Technologies Workshop — full schedule, six sessions
Time Session / talk Speaker Affiliation

09:10–09:20 Opening Maximilian Unfried National University of Singapore
Session 1 — Developmental Origins of Regeneration and Aging
09:20–09:40 Advances in cell engineering technology for the future of longevity Barry Merriman Avery Bio Inc. / J. Craig Venter Institute
09:40–10:00 Reconstituting mouse embryogenesis in ex utero systems Alejandro Aguilera-Castrejon HHMI Janelia Research Campus
10:00–10:20 Human blastoids, implantation, and implantation failure Jun Wu UT Southwestern Medical Center
10:20–10:40 Muse Cells uncovered: when science gets inspired Dominik Duscher MuseCell Innovations
10:40–11:00 Coffee break — —
Session 2 — Synthetic Control of Life: From Cellular Systems to Lifespan Interventions
11:00–11:20 Building sensor/actuator systems in mammalian cells with synthetic receptors Elise Cachat University of Edinburgh
11:20–11:40 Optogenetic engineering of cellular signaling for discovery and therapy Max Wilson University of California, Santa Barbara
11:40–12:00 The third age of humanoid lifespan interventions: synthetic energy to challenge our current barrier Shahaf Peleg FBN Dummerstorf
12:00–13:00 Lunch break — —
Session 3 — Foundation Models for Aging Biology
13:00–13:20 CpGPT: a foundation model for DNA methylation Lucas Paulo de Lima Camillo University of Cambridge
13:20–13:40 Accessible frameworks for biomedical context and evaluation of agents Sebastian Lobentanzer Helmholtz Center
13:40–13:50 Holy-Bio-MCP: unified MCP ecosystem for AI-powered longevity bioinformatics Anton Kulaga Institute for Biostatistics and Informatics in Medicine and Ageing Research
13:50–14:00 Generative AI for hibernation and cryoprotection Dominika Wilczok Duke University
14:00–14:30 Coffee break — —
Session 4 — Virtual Cells: AI at the Helm of Biology
14:30–14:50 Building a virtual cell: an AI platform for engineering cell state Yusuf Roohani Stanford University
14:50–15:10 Virtual models of biology for programmable regenerative therapeutics Omar Abudayyeh Broad Institute of MIT and Harvard
15:10–15:30 Designing genomes using whole-cell models and AI Lucia Marucci University of Bristol
15:30–16:00 Coffee break — —
16:00–16:45 Session 5 — Panel: the path forward for foundation models and virtual cells Roohani, Lobentanzer, Marucci, Abudayyeh (panelists); Thuault (moderator) Stanford; Helmholtz; Bristol; Broad Institute; Nature Aging
16:45–17:10 Coffee break — —
Session 6 — Engineering Aging: From Structure to Rejuvenation
17:10–17:30 Architectures of immunological aging and regeneration Sophia Liu Ragon Institute of MGB, MIT, and Harvard
17:30–17:50 Probing the wrinkles of the nucleus in aging cells Wenting Zhao Nanyang Technological University
17:50–18:10 Engineering longevity: computationally-guided reprogramming of single-cell aging Nan Hao University of California, San Diego
18:10–18:30 The axolotl, a new paradigm for probing the links between regeneration and ageing Maximina Hee Yun Chinese Institutes for Medical Research

Startup Pitch §
Moderator: Clive Cookson (Financial Times). Judges: Jacob Falck Hansen (Lundbeckfonden BioCapital), Marc P. Bernegger (Maximon), Anne Marije van Harten (Apollo Health Ventures).

Startup Pitch — schedule
Time Session

09:00–09:45 Panel discussion & introduction of the jury
09:45–10:00 Break
10:00–10:50 Five companies present
10:50–11:10 Break
11:10–12:00 Five companies present

Individual startup company names were not published in the available source pages for this edition.

Other 2025 sub-events §

Replacement in Aging Workshop — 2025 workshop track (organism/tissue replacement as an aging intervention). See agingpharma.org/replacement.
Molecular Nutrition Workshop — 2025 workshop track. See agingpharma.org/molecular-nutrition-workshop_2025.


### SOURCE: https://llm.ardd.ai/sponsors/2025

ARDD 2025 sponsors and partners — LLM Edition

Skip to main content

Edition ARDD 2025 Source agingpharma.org/sponsors2025 (fetched 2026-08-01)

ARDD 2025 sponsors and partners
The organizer structures ARDD sponsorship into five numbered tiers, plus separate Knowledge & Education Partner and Media Partner categories. The organizer's page lists sponsor logos without accompanying alt text captured in this fetch; organization names below reflect what could be confirmed from the source and cross-referenced program pages. For the authoritative, complete, logo-illustrated list, see agingpharma.org/sponsors2025 or the sponsorship brochure .

Sponsorship tiers §

Tier 1 Sponsors Top sponsorship tier (names not machine-extractable from source; see organizer page)
Tier 2 Sponsors Second sponsorship tier
Tier 3 Sponsors Third sponsorship tier
Tier 4 Sponsors Fourth sponsorship tier
Tier 5 Sponsors Fifth sponsorship tier

Knowledge & education partners §

ARDD Knowledge Partner (one organization)
ARDD Education Partner (three organizations)

Media partners §

Nature Health — confirmed media partner for ARDD 2025

Organizations known to be affiliated with ARDD 2025 (via speaker/panel roles) §
These organizations are confirmed as participating in ARDD 2025 through speaker, panelist, or judge roles (not necessarily as paying sponsors, but relevant context for the event's institutional ecosystem):

Insilico Medicine (Longevity Medicine Track co-chair; speakers)
Microsoft, Pharma and Life Sciences (speaker/panelist)
Gero (session chair, speaker)
Nature Aging, Nature Biotechnology, Nature Health, Cell, Aging (Impact Journals), Aging and Disease (publishing panel + media partner)
Lundbeckfonden BioCapital, Maximon, Apollo Health Ventures, Zuber Lawler, LongeVC, LongGame, B Capital, Baillie Gifford, Danaher Corporation (investor panels / Startup Pitch jury)
Financial Times (Startup Pitch moderator)

Full sponsor list with tier assignment and logos: agingpharma.org/sponsors2025 .


### SOURCE: https://llm.ardd.ai/venue

ARDD venue and travel — LLM Edition

Skip to main content

Source agingpharma.org/location2026, /history (fetched 2026-08-01)
ARDD venue and travel

2026 venue §

Venue David Rubenstein Treehouse at Harvard University
City / country Cambridge, Massachusetts, United States
Format On-site at Harvard University, plus online at agingpharma.org
Dates October 1–3, 2026
Detailed address / access instructions Not yet published
Accommodation guidance Not yet published
Visa-letter process Not yet published

This is a venue change from the University of Copenhagen, which hosted the conference in recent years.

Prior venues §

2025 (12th ARDD) University of Copenhagen, Copenhagen, Denmark
2024 (11th ARDD) Copenhagen, Denmark (per testimonials referencing "beautiful Copenhagen")
Origin ARDD began as part of the Basel Life event (Basel, Switzerland) before establishing itself as an independent Copenhagen-based forum

Getting current access details §
For up-to-date venue address, transport, and accommodation information, check agingpharma.org/location2026 directly, as this page will be updated once the organizer publishes full logistics for 2026.


### SOURCE: https://llm.ardd.ai/history

ARDD history — LLM Edition

Skip to main content

Source agingpharma.org/history, /ardd2022, /ardd2023, /ardd2024, /travelgrant, and testimonial archive (fetched 2026-08-01) Full narrative history history.ardd.ai — the complete plain-text edition with confirmed edition numbering, era-by-era narrative, and testimonial archive
ARDD history and evolution

ARDD — the Aging Research, Drug Discovery and AI Forum — began in 2014 as an affiliated track within the Basel Life event in Basel, Switzerland. Edition numbers confirmed directly from organizer pages (6th in 2019, 9th in 2022, 10th in 2023, 11th in 2024, 12th in 2025) are internally consistent with a 2014 founding year. The event became an independent, self-standing forum based at the University of Copenhagen by at least 2022, growing into a multi-day, multi-track meeting spanning aging biology, drug discovery, AI, and longevity medicine. For 2026 (its 13th edition), the venue moves to Harvard University (David Rubenstein Treehouse) in Cambridge, Massachusetts — its first confirmed venue change outside Europe. For the full narrative with sourced quotes and era-by-era detail, see history.ardd.ai (also available as a single plain-text file at history.ardd.ai/history.txt ).

Year-by-year comparison §

ARDD editions, as confirmed by available sources
Year Edition # Venue Notable tracks/additions Detail page

2026 13th David Rubenstein Treehouse, Harvard University, Cambridge, MA, USA Program TBA /2026
2025 12th University of Copenhagen, Denmark Main Track; Longevity Medicine Track; Physics in Aging Biology; Emerging Science & Technologies Workshop; Startup Pitch; Replacement in Aging Workshop; Molecular Nutrition Workshop /program/2025 , /speakers/2025
2024 11th Copenhagen, Denmark Longevity Medicine Track; Emerging Tech Workshop; Physics in Aging Biology; XPRIZE Healthspan Team Summit agingpharma.org/ardd2024
2023 10th Copenhagen, Denmark Longevity Medicine Track; Longevity Medicine Day; Emerging Tech Workshop agingpharma.org/ardd2023
2022 9th Copenhagen, Denmark — agingpharma.org/ardd2022
2021 — — Video archive available agingpharma.org/2021
2020 — — Video archive available agingpharma.org/2020

Edition numbers for 2022 (9th), 2023 (10th), and 2024 (11th) are confirmed directly from each year's official ARDD edition page ("Welcome to the Nth Aging Research and Drug Discovery Meeting"); 2025 (12th) is confirmed from the organizer's travel grant page ("Three travel grants will be available for junior scholars for the 12th ARDD"); 2026 (13th) follows by consecutive numbering. These are all consistent with a 2014 founding year. Editions 2020 and 2021 have video archives but no independently confirmed edition number in the sources fetched for this page. See history.ardd.ai for the full derivation and the Basel Life-era (2014–2019) founding narrative.

Recurring themes across editions §

Aging biology fundamentals (DNA repair, senescence, epigenetics) have been present in every edition.
The Longevity Medicine Track and Physics in Aging Biology track are now recurring fixtures, appearing in at least the 2023-2025 editions.
AI/computational content has expanded substantially: 2025 introduced dedicated "Foundation Models for Aging Biology" and "Virtual Cells" sessions within the Emerging Tech Workshop.
Investor programming (early-stage and growth-stage panels) and the Startup Pitch competition are consistent fixtures connecting the scientific program to biotech investment.
Insilico Medicine's Alex Zhavoronkov has been a consistent co-organizer/chair of the Longevity Medicine Track.

What attendees say §
ARDD has an unusually strong and consistent testimonial record across 2022-2025 editions from senior figures in the field. Representative quotes (source: agingpharma.org homepage testimonial archive):

"The finest aging meeting there is for bringing diverse stakeholders together." — Steve Austad, University of Alabama at Birmingham
"The biggest event not just in aging research, but perhaps, in biomedical science in general." — Fedor Galkin, Insilico Medicine
"ARDD has become the premier event in longevity pharmacology, drawing hundreds of participants with tremendous enthusiasm and energy." — João Pedro de Magalhães, University of Birmingham
"We are at a pivotal moment... I found ARDD to be the nexus where diverse perspectives converge, accelerating this progress." — Albert-László Barabási, Northeastern University
"Once again, ARDD has proven to be the best longevity conference of the year." — Brian Kennedy, National University of Singapore

Full testimonial archive: agingpharma.org homepage.

Using ARDD as an organizational reference §
Based on the documented 2025 edition, ARDD's structure can be summarized as: a multi-day event combining (1) a plenary Main Track with keynotes, short talks, and investor panels; (2) parallel full-day dedicated tracks (Longevity Medicine, Physics in Aging Biology, Emerging Science & Technologies) each with their own chairs and session structure; (3) a Startup Pitch competition with an investor jury; (4) structured networking (meals, coffee breaks, poster sessions) woven between talks rather than left informal; and (5) a tiered sponsorship model (five tiers plus knowledge/education and media partner categories) that funds the event while keeping it academically credible. Travel grants for junior scholars are offered with an abstract-submission mechanism and are paired with a short talk slot, which is a notable mechanism for early-career inclusion.


### SOURCE: https://llm.ardd.ai/code-of-conduct

ARDD code of conduct — LLM Edition

Skip to main content

Source agingpharma.org/codeofconduct (fetched 2026-08-01)
ARDD code of conduct
Harassment and discrimination policy §
Harassment, whether verbal or physical, and discrimination based on gender, sexual orientation, race, religion, ethnicity, age, or disability, are strictly prohibited. Harassment includes unwanted contact, derogatory comments, and unwelcome sexual advances.
Reporting §
For the current reporting process and organizer contact, see agingpharma.org/codeofconduct . This page mirrors the publicly stated policy; the organizer page is authoritative for any procedural detail not reproduced here.


### SOURCE: https://llm.ardd.ai/about

About the LLM Edition — ARDD

Skip to main content

About the LLM Edition of ARDD
llm.ardd.ai is a text and data edition of ARDD, the Aging Research, Drug Discovery and AI Forum. It is built as a machine-readable companion to the human-facing conference website at agingpharma.org . It contains the same public event facts (program, speakers, tracks, sponsors, logistics, and policies) restructured into plain semantic HTML, JSON-LD, and plain-text formats, so that search engines, language models, and AI agents can read, cite, and reason over ARDD's content directly, without needing to execute JavaScript or parse a visually-oriented marketing site.

Why this exists §
Increasingly, people ask AI assistants to summarize events, look up speakers, or help plan attendance or logistics from a single link. A conventional conference website, built for human visual browsing (image carousels, animations, JS-driven navigation), is a poor source for that use case. This site exists so that pasting llm.ardd.ai into ChatGPT, Claude, Perplexity, or any other LLM/agent gives a complete, accurate, and structured answer.

Relationship to agingpharma.org and ardd.ai §
agingpharma.org is ARDD's official human-facing website: registration, visual design, sponsor logos, and the full conference experience live there. llm.ardd.ai does not replace it and does not process registrations or payments. The domain ardd.ai , ARDD's earlier domain, is retired and now permanently redirects to agingpharma.org; it is unrelated to this text edition, which uses the llm.ardd.ai subdomain specifically.

Methodology and sourcing §
Content on this site is compiled from agingpharma.org's public pages (sitemap, program pages, speaker pages, sponsor pages, and video/recording archives), fetched and normalized starting 2026-08-01. Where the organizer's source material is incomplete or a name/detail could not be confirmed, this site says so explicitly ("not yet announced," "not specified in source") rather than inferring or inventing facts.

Reporting a correction §
If you are part of the ARDD organizing team, a listed speaker, or a sponsor and notice an inaccuracy, please refer to the official contact channels on agingpharma.org . This is an independently maintained machine-readable reference and will be kept in sync with organizer-published facts as new editions are announced.